期刊文献+

Castleman病转化为霍奇金淋巴瘤一例并文献复习 被引量:1

A case report Of Castleman's disease transformed into Hodgkin's lymphoma with literature review
原文传递
导出
摘要 目的 分析Castleman病的病因及发病机制、临床及病理特点、诊断、治疗及预后。方法 对1例Castleman病转化为霍奇金淋巴瘤的病例进行分析并进行文献综述。结果 Castleman病是一种以滤泡增生和毛细血管增生为组织学特征的淋巴结良性增生性疾病。根据病理学特点分为透明血管(HV)型、浆细胞(PV)型及兼有两者特点的混合细胞型。其临床表现复杂多变,除淋巴结肿大外尚可有全身表现及多系统受累症状,早期确诊主要靠组织病理学诊断,病理类型不同预后也不同,局灶型(LCD)患者预后良好,可能长期带病生存,多中心型(MCD)具有侵袭性,预后差。结论 Castleman病不同的病理类型其临床表现及预后也不同。 Objective To understand the cause and pathogenesis,clinical and pathological features,diagnosis,treatment and prognosis of Castleman's disease (CD). Methods One patient with CD which has transformed into Hodgkin's lymphoma in the end was analyzed and the review were included. Results Castleman's disease was a lymphoproliferative disorder with benign hyperplastic lymphnodes histologically characterized by follicular hyperplasia and capillary proliferation with endothelial hyperplasia. Based on the characteristic of pathology it was subdivided into three subtypes, hyaline vascular variant, plasma cell variant and mixed variant. The clinical manifestation of CD was multiplicity,including the lymphadenectasis and the involvement of the multisystem of the body. The early diagnosis was depended on the histopathology,and the different histopathology has the distinct prognosis. The prognosis of local Castleman's disease (LCD) was good but the multicentric Castleman's disease (MCD) was poor. Conclusion The different histopathology of CD were determined according to the different clinical manifestations and prognosis.
作者 王晶 陈文明
出处 《白血病.淋巴瘤》 CAS 2009年第11期684-686,共3页 Journal of Leukemia & Lymphoma
关键词 巨淋巴结增生 霍奇金病 Giant lymph node hyperplasia Hodgkin disease
  • 相关文献

参考文献9

  • 1刘宁,邱法波,李奉达.Castleman's病流行病学及临床特征[J].世界华人消化杂志,2008,16(30):3469-3473. 被引量:44
  • 2Du MQ, Liu H, Diss TC, et al. Kaposi sarcoma-associated herpervirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders. Blood, 2001, 97:2130-2136.
  • 3Fukino S, Futata T, Haya.shi E, et al. Castleman lymphoma originated from the posterior mediasinum resected thoracoscapocally: report of a case. Kyobu Geka, 2002, 55:519-522.
  • 4Du MQ, Diss TC, Liu H, et al. KSHV and EBV-associated germinotropic lymphoproliferative disorder. Blood, 2002, 100: 3415-3418.
  • 5Norihiro N, Mitsuko S, Yoshihito S, et al. Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy. Blood, 2000, 95: 56-63.
  • 6张仪,李甘地,刘卫平.Castleman病的病因和发病机制研究进展[J].中华病理学杂志,2005,34(12):812-815. 被引量:55
  • 7Frizzera G. Castleman's disease and related disorders. Semin Diag Pathol, 1988, 82: 346-364.
  • 8Marcelin AG, Aaron L, Mateus C, et al. Rituximab therapy for HIV -associated Castleman disease. Blood, 2003, 102: 2786-2788.
  • 9Kanda J, Kawabata H, Yamaji Y, et al. Reversible cardiomyopathy associated with muhicentric Castleman disease:successful treatment with tocilizumab,an anti-interleukin 6 receptor antibody. Int J Hematol, 2007, 85:207-211.

二级参考文献56

共引文献95

同被引文献1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部